The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(4-Amino-7-benzyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea ID: ALA4551816
PubChem CID: 155555805
Max Phase: Preclinical
Molecular Formula: C27H27N7O2
Molecular Weight: 481.56
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(Cc4ccccc4)c4ncnc(N)c34)cc2)no1
Standard InChI: InChI=1S/C27H27N7O2/c1-27(2,3)21-13-22(33-36-21)32-26(35)31-19-11-9-18(10-12-19)20-15-34(14-17-7-5-4-6-8-17)25-23(20)24(28)29-16-30-25/h4-13,15-16H,14H2,1-3H3,(H2,28,29,30)(H2,31,32,33,35)
Standard InChI Key: VXPZMKHJUJLFES-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
31.7156 -3.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4213 -4.2039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4172 -5.0211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1310 -3.7989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1230 -4.6089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5804 -5.7286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.5792 -6.5481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2873 -6.9571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2855 -5.3197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9941 -5.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9989 -6.5436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7789 -6.7920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2563 -6.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7712 -5.4675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2830 -4.5025 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1917 -7.4972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1843 -4.7632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0022 -4.7744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4161 -4.0707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0128 -3.3589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1913 -3.3554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7812 -4.0597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4257 -2.6538 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2429 -2.6588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6559 -1.9537 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6471 -3.3690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4643 -3.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9369 -4.0394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7207 -2.9745 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.9451 -2.7173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0089 -7.4924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4178 -8.1994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2342 -8.1949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6394 -7.4843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2222 -6.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4072 -6.7847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
2 5 1 0
6 7 2 0
7 8 1 0
8 11 2 0
10 9 2 0
9 6 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
9 15 1 0
12 16 1 0
14 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 1 0
24 25 2 0
24 26 1 0
26 27 1 0
27 28 1 0
28 1 2 0
1 29 1 0
29 30 1 0
30 27 2 0
16 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 481.56Molecular Weight (Monoisotopic): 481.2226AlogP: 5.66#Rotatable Bonds: 5Polar Surface Area: 123.89Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.27CX Basic pKa: 6.13CX LogP: 5.45CX LogD: 5.37Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.30Np Likeness Score: -1.35
References 1. Yuan X, Chen Y, Zhang W, He J, Lei L, Tang M, Liu J, Li M, Dou C, Yang T, Yang L, Yang S, Wei Y, Peng A, Niu T, Xiang M, Ye H, Chen L.. (2019) Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia., 62 (8): [PMID:30939008 ] [10.1021/acs.jmedchem.9b00223 ]